AU712575B2 - Peptides which bind to prothrombin and thrombin - Google Patents

Peptides which bind to prothrombin and thrombin Download PDF

Info

Publication number
AU712575B2
AU712575B2 AU26220/97A AU2622097A AU712575B2 AU 712575 B2 AU712575 B2 AU 712575B2 AU 26220/97 A AU26220/97 A AU 26220/97A AU 2622097 A AU2622097 A AU 2622097A AU 712575 B2 AU712575 B2 AU 712575B2
Authority
AU
Australia
Prior art keywords
thrombin
peptide
seq
leu
gly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU26220/97A
Other languages
English (en)
Other versions
AU2622097A (en
Inventor
George A Baumbach
Joseph A. Buettner
Christopher A. Dadd
David J Hammond
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Corp
Original Assignee
Bayer AG
Bayer Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG, Bayer Corp filed Critical Bayer AG
Publication of AU2622097A publication Critical patent/AU2622097A/en
Application granted granted Critical
Publication of AU712575B2 publication Critical patent/AU712575B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6429—Thrombin (3.4.21.5)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21005—Thrombin (3.4.21.5)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Saccharide Compounds (AREA)
AU26220/97A 1996-06-28 1997-06-23 Peptides which bind to prothrombin and thrombin Ceased AU712575B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/672805 1996-06-28
US08/672,805 US5831003A (en) 1996-06-28 1996-06-28 Peptides which bind to prothrombin and thrombin

Publications (2)

Publication Number Publication Date
AU2622097A AU2622097A (en) 1998-01-15
AU712575B2 true AU712575B2 (en) 1999-11-11

Family

ID=24700072

Family Applications (1)

Application Number Title Priority Date Filing Date
AU26220/97A Ceased AU712575B2 (en) 1996-06-28 1997-06-23 Peptides which bind to prothrombin and thrombin

Country Status (10)

Country Link
US (1) US5831003A (enExample)
EP (1) EP0816377B1 (enExample)
JP (1) JP3978258B2 (enExample)
AT (1) ATE215964T1 (enExample)
AU (1) AU712575B2 (enExample)
CA (1) CA2206663A1 (enExample)
DE (1) DE69711765T2 (enExample)
DK (1) DK0816377T3 (enExample)
ES (1) ES2175218T3 (enExample)
PT (1) PT816377E (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6462180B1 (en) * 1999-11-24 2002-10-08 Bayer Corporation Method of preparing α-1 proteinase inhibitor
FI1343809T4 (fi) 2000-12-14 2023-09-04 Menetelmä alfa-1 proteinaasinestäjän valmistamiseksi
GB0211849D0 (en) * 2002-05-23 2002-07-03 Mok Kenneth H Improvments to retro-inverso isomers
FR2884418B1 (fr) * 2005-04-15 2008-11-21 Soc Extraction Principes Actif Utilisation d'un peptide comme principe actif amincissant
CA2655933C (en) 2006-06-23 2014-09-09 Alethia Biotherapeutics Inc. Polynucleotides and polypeptide sequences involved in cancer
CN104829714A (zh) 2008-11-03 2015-08-12 阿莱斯亚生物疗法股份有限公司 特异性地阻滞肿瘤抗原的生物活性的抗体
US8945895B2 (en) 2009-07-31 2015-02-03 Baxter International Inc. Methods of purifying recombinant ADAMTS13 and other proteins and compositions thereof
CA2893376A1 (en) 2011-03-31 2012-10-04 Alethia Biotherapeutics Inc. Antibodies against kidney associated antigen 1 and antigen binding fragemnts thereof
AU2013209234B2 (en) 2012-01-09 2017-11-09 Adc Therapeutics Sa Method for treating breast cancer
JP6713479B2 (ja) 2015-02-25 2020-06-24 オムリックス・バイオファーマシューティカルズ・リミテッドＯｍｒｉｘ Ｂｉｏｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｔｄ． トロンビン及びその分解ポリペプチドの精製及び定量化方法
ES2791982T3 (es) * 2015-02-25 2020-11-06 Omrix Biopharmaceuticals Ltd Método para purificar y cuantificar la trombina y sus polipéptidos de degradación

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341032C (en) * 1987-01-23 2000-06-20 John L. Krstenansky Anticoagulant peptides
US5367060A (en) * 1991-05-24 1994-11-22 Genentech, Inc. Structure, production and use of heregulin

Also Published As

Publication number Publication date
JPH1075778A (ja) 1998-03-24
EP0816377B1 (en) 2002-04-10
JP3978258B2 (ja) 2007-09-19
DE69711765T2 (de) 2002-10-02
US5831003A (en) 1998-11-03
AU2622097A (en) 1998-01-15
EP0816377A2 (en) 1998-01-07
DE69711765D1 (de) 2002-05-16
ATE215964T1 (de) 2002-04-15
CA2206663A1 (en) 1997-12-28
EP0816377A3 (en) 1998-07-15
DK0816377T3 (da) 2002-07-22
PT816377E (pt) 2002-08-30
ES2175218T3 (es) 2002-11-16

Similar Documents

Publication Publication Date Title
Kisiel Human plasma protein C: isolation, characterization, and mechanism of activation by α-thrombin
US5200510A (en) Method for purifying factor viii:c, von willebrand factor and complexes thereof
Beintema et al. Amino acid sequence of the nonsecretory ribonuclease of human urine
Boissel et al. Covalent structures of beta and gamma autolytic derivatives of human alpha-thrombin.
Andersson et al. Purification and characterization of human factor IX
CN101730707B (zh) 使用混合式或多模式树脂来纯化因子ⅷ
JP2009524622A (ja) 創傷治癒支援因子の精製および使用
US5831003A (en) Peptides which bind to prothrombin and thrombin
US6677440B1 (en) Process for the preparation in pure form of the protease activating blood clotting factor VII, its proenzyme or a mixture of both proteins by means of ion-exchange chromatography
CA2282842C (en) A method of recovering highly purified vwf or factor viii/vwf-complex
Mahoney et al. Formation and Dissociation of the Covalent Complexes Between Trypsin and Two Homologous Inhibitors, α1‐Antitrypsin and Antithrombin III
Takagi et al. Amino acid sequence of the carboxy-terminal cyanogen bromide peptide of the human fibrinogen β-chain: Homology with the corresponding γ-chain peptide and presence in fragment D
US6034222A (en) Method for the separation of recombinant pro-factor IX from recombinant factor IX
Spycher et al. Human complement component C1¯ s: Partial sequence determination of the heavy chain and identification of the peptide bond cleaved during activation
EP0789030A1 (en) Fibrinogen binding peptides
Kerr [6] The second component of human complement
US6191256B1 (en) Recombinant factor VIII binding peptides
Clifton et al. Use of proteomics for validation of the isolation process of clotting factor IX from human plasma
Wun et al. Comparison of recombinant tissue factor pathway inhibitors expressed in human SK hepatoma, mouse C127, baby hamster kidney, and Chinese hamster ovary cells
Herion et al. Purification of urokinase by monoclonal antibody affinity chromatography
Girolami et al. Hydrolysis of rat high molecular weight kininogen by purified rat urinary kallikrein: identification of bradykinin as the kinin formed
EP3205665A1 (en) Method of separating factor viii from blood products
O'Brien et al. Structural requirements for the interaction between tissue factor and factor VII: characterization of chymotrypsin-derived tissue factor polypeptides
HUP9903789A2 (hu) von Willebrand-faktor származék, valamint eljárás proteinek izolálására
Nustad et al. Glandular kallikreins: Purification, characterization, and biosynthesis